Finally, Bank of America upped their target price on IDEXX Laboratories from $300.00 to $390.00 and gave the company a “buy” rating in a report on Monday, July 20th. IDEXX Laboratories has received 478 “outperform” votes. Die dicken Nachrichten kommen erst noch“, SENSATIONELLE NEWS von MAWSON in Finnland! How is the medical sector tackling infertility? ET by Tomi Kilgore The S&P 500 just hit a record high — so did these stocks View recent trades and share price information for IDEXX Laboratories Inc Common Stock USD0.10 Zu diesem Wertpapier gibt es bereits 15 Beiträge! 3 analysts have issued 1 year price objectives for IDEXX Laboratories' stock. Identify stocks that meet your criteria using seven unique stock screeners. Learn everything you need to know about successful options trading with this three-part video course. © American Consumer News, LLC dba MarketBeat® 2010-2020. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. IDEXX Laboratories, Inc. Common Stock (IDXX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GuruFocus rated IDEXX Laboratories Inc the business predictability rank of 5-star. IDEXX Laboratories had a return on equity of 198.91% and a net margin of 19.20%. Company insiders that own IDEXX Laboratories stock include Brian P Mckeon, Bruce L Claflin, Daniel M Junius, Giovani Twigge, Jacqueline Studer, James F Polewaczyk, Jay Mazelsky, Jonathan Jay Mazelsky, Jonathan W Ayers, Lawrence D Kingsley, M Anne Szostak, Michael Lane, Nimrata Hunt, Rebecca M Henderson and Sophie V Vandebroek. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. The Company reports revenues of $722 million for the third quarter … Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 44/20, Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 35/20, Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 30/20, Hast du 1.000 Dollar zum Investieren? BlackRock Inc. now owns 7,760,098 shares of the company’s stock valued at $3,050,572,000 after purchasing an additional 258,375 shares during the period. The company earns $427.72 million in net income (profit) each year or $4.89 on an earnings per share basis. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Can Diagnostics Aid Hologic (HOLX) Q4 Sales Amid Coronavirus? IDEXX Laboratories has received a consensus rating of Buy. Looking for new stock ideas? DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates. the views of the author. Owens & Minor (OMI) to Report Q3 Earnings: What's in Store? NYSE +20 Min. Coronavirus - we're here to help Try our handy filter to explore the different options. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View which stocks have been most impacted by COVID-19. (Add your “underperform” vote.). Please log in to your account or sign up in order to add this asset to your watchlist. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 IDEXX Laboratories' mailing address is ONE IDEXX DRIVE, WESTBROOK ME, 04092. FDA video warns pet owners about spreading COVID-19, Second dog tests positive for coronavirus as owners warned not to abandon pets, Hong Kong Pet dog that tested for coronavirus dies after returning from quarantine virus-free, These U.S. stocks skidded the most Tuesday as the market slides for the fourth straight day, Looking for another Apple or Amazon? View IDEXX Laboratories' earnings history. IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories has a PEG Ratio of 4.92. By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Following the completion of the sale, the director now directly owns 742,535 shares of the company’s […] Cookie Notice. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Company insiders that have sold IDEXX Laboratories company stock in the last year include Brian P Mckeon, Bruce L Claflin, Daniel M Junius, Giovani Twigge, James F Polewaczyk, Jonathan Jay Mazelsky, Jonathan W Ayers, M Anne Szostak, Michael Lane, Nimrata Hunt, and Rebecca M Henderson. Get short term trading ideas from the MarketBeat Idea Engine. Medical Products' Oct 29 Earnings Roster: SYK, BAX & More, Masimo (MASI) Earnings and Revenues Beat Estimates in Q3, Varian (VAR) Earnings and Revenues Surpass Estimates in Q4, Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season. Henry Schein (HSIC) to Report Q3 Earnings: What's in Store. View analysts' price targets for IDEXX Laboratories. Have Watchlists? AMEX +20 Min. IDXX stock opened at $478.10 on Monday. here to help. Learn about financial terms, types of investments, trading strategies and more. The latest IDEXX Laboratories Inc Common Stock USD0.10 share price. CEO Recent Trades: President & CEO Jonathan Jay Mazelsky sold 5,206 shares of IDXX stock on 11/05/2020 at the average price of $469.31. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. By using this site you agree to the BlackRock Inc. grew its holdings in IDEXX Laboratories by 3.4% during the third quarter. Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? Earnings for IDEXX Laboratories are expected to grow by 11.71% in the coming year, from $5.72 to $6.39 per share. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Some companies that are related to IDEXX Laboratories include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Steris (STE) and Varian Medical Systems (VAR). Das Unternehmen unterstützt Tierarztpraxen dabei, ihre medizinische Versorgung weiterzuentwickeln und die Rentabilität der Einrichtungen zu steigern. Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar? It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. In the past three months, IDEXX Laboratories insiders have sold more of their company's stock than they have bought. agencies. IDEXX Laboratories' stock was trading at $245.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. On average, research analysts expect that IDEXX Laboratories, Inc. will post 6.03 earnings per share for the current year. X. Export data to Excel for your own analysis. Their forecasts range from $375.00 to $422.00. Derivate Cockpit - Finden Sie das beste Produkt zu Ihrer Kurserwartung auf IDEXX Laboratories, Top 15 der gesamten Suchanfragen der letzten 7 Tage. Several brokerages have recently commented on IDXX. The stock was sold at an average price of $471.90, for a total value of $5,398,536.00. 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IDEXX Laboratories in the last year. Fundamental company data provided by Morningstar and Zacks Investment Research. Third Quarter Results. On average, they anticipate IDEXX Laboratories' share price to reach $395.67 in the next twelve months. The stock was sold at an average price of $471.90, for a total value of $5,398,536.00. Aperio Group LLC now owns 60,565 shares of the company’s stock valued at $23,809,000 after purchasing an additional 2,827 shares during the period. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Sei Investments Co. grew its holdings in IDEXX Laboratories by 62.3% during the third quarter. Vote “Underperform” if you believe IDXX will underperform the S&P 500 over the long term. The official website for IDEXX Laboratories is www.idexx.com. Der Hauptsitz ist Westbrook, Maine. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Don’t let B2B payments limit your business returns – Know how to make things better, Tips to finding a business for sale – Knowing your options, Seattle Ready to Repeal Taxes on Larger Employers, Ten young American entrepreneurs who are shaking up their industries, Teamsters and UPS Might Be On Course for Large Labor Strike, Ways to Show Customers the Usefulness of Your Ecommerce Products, Europe Shoots Back at U.S. Over Steel Tariffs, Oil Workers Strike in Brazil in Another Hit to the Government, Two of the Biggest Brands in the World Are Chinese, US Crude Prices Plummet 4% as Russia and OPEC Consider Easing Caps. The selling price currently displayed is higher than the buying price. Do Not Sell My Information. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Subscriber Agreement & Terms of Use, Intraday data delayed at least 15 minutes or per exchange requirements. IDEXX Laboratories, Inc, together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories' stock was trading at $245.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). IDEXX Laboratories’s quarterly revenue was up 19.2% on a year-over-year basis. View which stocks are hot on social media with MarketBeat's trending stocks report. Earnings for IDEXX Laboratories are expected to grow by 12.60% in the coming year, from $6.03 to $6.79 per share.